TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Stability in maximum and mean keratometric diopters (Kmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Belin-Ambrosio ectasia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prenatal Father Attachment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Semantic Differential Scale-Me as a Mother
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Semantic Differential Scale-My Baby
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of Engraftment of Hepatocytes
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of Engraftment of Hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past month drunkenness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Concentration-time Profile From Time Zero to 14 Days (AUC14day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in OSI questionnaire scales
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average improvement in Perceived Stress Scale (PSS) test scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in nipple areolar complex diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of SNPs associated with Heart Attack
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of aggressive thyroid cancers
Endpoint domain: Mortality/survival
Primary endpoint: The classification of the surgical field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intensity and duration of urethral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with urethral bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of urethral perforation with fistula or perineal soft tissue infection
Endpoint domain: Adverse events/effects
Primary endpoint: Radiological progression to ARCO Stage III or IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain using the Pain VAS scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to failure of femoral head
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Best overall response rate (BORR) to pembrolizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ghrelin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cholecystokinin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Any treatment-related adverse events and side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Modulations in the amplitude of the LFP power spectrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained remission through Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant perception and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fatigue variation
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of hospital readmissions for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Fluctuation of CGRP during the ovarian cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fluctuation of SP during the ovarian cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fluctuation of VIP during the ovarian cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fluctuation of enkephalins during the ovarian cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Blood parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Lower Quarter Y-Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in 10-Meter Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Timed Up and Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Four Step Square Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manchester Oxford Foot Questionnaire (MOxFQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean Monocular Distance Corrected Intermediate Visual Acuity (DCIVA) - First Eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Monocular Distance Corrected Near Visual Acuity (DCNVA) - First Eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant changes in HIV viral load in pregnant participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ELISA-measured IgG antibody levels greater than or equal to 0.35ug/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean pain measured by Visual Analog Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of participants retained on PrEP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants retained on PrEP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in subjective stress response
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Standard deviation of all NN (SDNN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment Emergent Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of children referred to a higher level of care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Adherence to antidepressants during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Time for requirement of first rescue analgesic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serotype-specific immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the curve from time zero to last measurable time point (AUC 0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from time zero to infinity (AUC 0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes and experiences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: systolic blood pressure measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic blood pressure measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic performance (sensitivity, sensibility)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Korean Household Emergency Preparedness Instrument (K-HEPI) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Innovation-Values fit from Baseline to Month 6
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Innovation-Values fit from Baseline to Month 12
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Participants' Moderate to Vigorous Physical Activity (MVPA) from Baseline to Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Participants' Moderate to Vigorous Physical Activity (MVPA) from Baseline to Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: World Health Organization (Five) Well-Being Index (WHO-5) change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EQ-5D-5L change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diabetes Distress Scale (DDS) change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hypoglycemic Confidence Scale (HCS) change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression to PDR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: sagittal dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dental dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic profile difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post operatory pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mechanical fall
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of service at 20 s (QS20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve to the last measured timepoint (AUCT) for CBD metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve to the last measured timepoint (AUCT) for THC metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) for CBD metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) for THC metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum concentration (Tmax) for CBD metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who maintained their weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants who lost more than or equal to 5% of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Volume of mass on as visualized on contrast (Lumason) enhanced ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contrast (Lumason) enhanced ultrasound metric-area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who respond to treatment as reported on routine imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency, severity and causality of acute adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain intensity measured by VNRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in complementary feeding practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PhotoNode Score interobserver agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic progression free survival (rPFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Participant non-adherence to colonoscopy check-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Children's acceptance after intake of midazolam rated by research staff
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's acceptance after intake of midazolam rated by the pediatric patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Desaturation (≤95%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AUCτ of edoxaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Css,max of edoxaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCτ of apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Css,max of apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCτ of rivaroxaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Css,max of rivaroxaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: KAP questionnaire on ergonomics in dentistry
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Heterotropic ossification incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ICIQ-OAB-QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain-free mandibular opening range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunological Marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: DXA Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD-RISC (Connor-Davidson Resilience Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ECOM (Emotional Coping and Management)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of screw implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in negative emotional responding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of Participants with polymorphism in the IL-1 gene cluster
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in confidence scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in competency scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Grade III-IV GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Grade II GVHD requiring systemic treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of severe neutropenia requiring growth factor support
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of gastric neoplastic lesions detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in azoturia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in distance covered
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in Perceived Stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to calculate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficacy of Endovascular Treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time-averaged serum concentration over 28 days after the first dose (Cavgd28) of Nivolumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough serum concentration at steady state (Cminss) of Nivolumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cavgd28 of Relatlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cminss of Relatlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change from Baseline in Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI-A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: British Isles Lupus Assessment Group (BILAG)-Based Composite Lupus Assessment (BICLA) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body Sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of Adversity History on Music Listening Effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neural responses to rewards measured by EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mayo Elbow Performance Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of catheter related vascular thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: 59Fe non-heme iron absorption from cod and beef protein meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 55Fe non-heme iron absorption from fava bean protein meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tendency to suicide
Endpoint domain: Adverse events/effects
Primary endpoint: Screen-time
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety of CELZ-201-DDT
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-reported bowel function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overground ambulation [as appropriate to the subject] (1)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of hypotension events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Protection from pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Composite incidence of death, myocardial infarction and urgent target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Muscular functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood marker of collagen synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Session Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Social and Occupational Functioning Assessment Scale (SOFAS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Tissues and biofluid spectra
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent patellar dislocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: perceived depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Length of fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMV-CMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EBV-CMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of Postoperative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: 24-h movement behaviors (accelerometers) sedentary time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h movement behaviors (accelerometers) physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h movement behaviors (accelerometers) sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in cardiovascular risk factor score blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cardiovascular risk factor score LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cardiovascular risk factor score HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cardiovascular risk factor score BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cardiovascular risk factor score physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cardiovascular risk factor score nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in microbial composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of autonomous parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine Disability Assessment questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Brief Illness Perception questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neuromuscular electrical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constant Work Rate Exercise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary study endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes